Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Use of Peripherally Inserted Central Catheter (PICC) for the Infusion of Peripheral Blood Stem Cell Products Is Safe and Effective

Shi Hui Clarice Choong, Michelle Poon, MBBS, MRCP, FRCPATH, Teck Guan Soh, Jedidah Lieow, BSc,MSN, Lip Kun Tan, MBBS, FRCP, FRCPath, Liang Piu Koh, MBBS, MRCP, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, Yee Mei Lee, BSN, MN, PhD, Joanne Shu Xian Lee, MBBS, MRCP, Davanaliz Gonzales Ramos, Eng Soo Yap, MBBS, MMed (Int MD, MRCP, FRCPath Haematology

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-141719

Published: 2020

Journal Articles

Prognostic Value of Refined Disease Risk Index (rDRI) and Conditioning Regimen in Adult Patients Receiving Unrelated Cord Blood Transplantation (UCBT) for Haematological Malignancies - 15-Year Follow-up of Multicenter Study in Singapore

Qianhuang Ian Q Wu, MBBS, Yeh Ching Linn, MBBS, MRCP, William YK Hwang, MBBS, Michelle Poon, MBBS, MRCP, FRCPATH, Lip Kun Tan, MBBS, FRCP, FRCPath, Yang Liang Boo, MD, Yeow Tee Goh, MBBS, Aloysius YL Ho, MBBS,FRCP,FRCPath, Liang Piu Koh, MBBS, MRCP

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141581

Published: 2020

Journal Articles

Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2 (JAK2), in Patients with Intermediate-2 or High-Risk Myelofibrosis (MF): Updated Results from the Randomized, Placebo-Controlled, Phase III JAKARTA Trial

Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Tamas Masszi, MD, Elena Mishchenko, MD, Mark W. Drummond, PhD FRCPath, Eric Jourdan, MD, Alessandro M. Vannucchi, MD, Mindaugas Jurgutis, Vincent Ribrag, MD, Alessandro Rambaldi, MD PhD, Liang Piu Koh, MBBS, MRCP, Shelonitda Rose, MD, Jun Zhang, PhD, Claire Harrison, DM, FRCP, FRCPath

Blood (2020) 136 (Supplement 1): 10–12.

https://doi.org/10.1182/blood-2020-137279

Published: 2020

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies: Three-Year Follow-up of Multicenter Study in Singapore

Yang Liang Boo, MD, Yeh Ching Linn, MBBS, MRCP, Rajat Bhattacharyya, Michelle Li Mei Poon, MBBS, MRCP, Zi Yi Lim, MB ChB, Michaela Su-Fern Seng, MBBS, Poh Lin Tan, MBBS, Colin Phipps Diong, MB BCh BAO, Balamurugan Vellayappan, MBBS, Ah Moy Tan, MD, Lip Kun Tan, MBBS, FRCP, FRCPath, Yvonne Su Ming Loh, MBBS, Teck Guan Soh, Gina Gan, Yin Jie Koh, Wing Hang Leung, MBBS, Liang Piu Koh, MBBS, MRCP

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-138638

Published: 2020

Journal Articles

High Dose Flamsa, CLAG or FLAG-Based Sequential Conditioning Regimen Followed By Allogeneic Hematopoietic Transplantation Results in Favorable Outcome for High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasia Patients : A Multicenter Study in Singapore

Lip Leong Chong, MDMRCP, Yang Liang Boo, MD, Yin Jie Koh, Michelle Poon, MBBS, MRCP, FRCPATH, Yeh Ching Linn, MBBS, MRCP, William YK Hwang, MBBS, Aloysius YL Ho, MBBS,FRCP,FRCPath, Elson Neo, Lip Kun Tan, MBBS, FRCP, FRCPath, Liang Piu Koh, MBBS, MRCP

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-141518

Published: 2020

Journal Articles

Autologous Stem Cell Transplantation (ASCT) for T-Cell Non Hodgkin Lymphoma (T-NHL) Patients Who Achieve Complete Remission with First-Line Treatment: A Systematic Review and Meta-Analysis

Yin Jie Koh, Louis-Pierre Girard, MBChB, Hian Li Esther Hian Li Chan, MRCP, FRCPATH, Joanne Shu Xian Lee, MBBS, MRCP, Yen-Lin Chee, MBChB, FRCPath, PhD, Anand Jeyasekharan, Sanjay de Mel, MRCP(UK) FRCPath, Cinnie Yentia Soekojo, MD, Xin Liu, Liang Piu Koh, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Miny Samuel

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-138700

Published: 2020

Journal Articles

Unmanipulated Haploidentical Transplant Followed By Post-Transplant Cyclophosphamide and Selective Ex Vivo T-Cell Depleted Haploidentical Transplant Results in Comparable Outcome As Unrelated Cord Blood Transplant for Adults with Haematological Malignancies- a Multicenter Study in Singapore

Cheryl XQ Lim, MBBS,MRCP, Yeh Ching Linn, MBBS, MRCP, Yin Jie Koh, Michelle Poon, MBBS, MRCP, FRCPATH, Aloysius YL Ho, MBBS,FRCP,FRCPath, William YK Hwang, MBBS, FRCP, Lip Kun Tan, MBBS, FRCP, FRCPath, Liang Piu Koh, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 4588.

https://doi.org/10.1182/blood-2019-125261

Published: 2019

Journal Articles

High Dose Flamsa, CLAG or FLAG-Based Sequential Conditioning Regimen Followed By Allogeneic Hematopoietic Transplantation Results in Favorable Outcome for High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasia Patients: A Multicenter Study in Singapore

Yin Jie Koh, Michelle Poon, MBBS, MRCP, FRCPATH, Yeh Ching Linn, MBBS, MRCP, William YK Hwang, MBBS, FRCP, Elson Neo, Aloysius YL Ho, MBBS,FRCP,FRCPath, Lip Kun Tan, MBBS, FRCP, FRCPath, Liang Piu Koh, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 4509.

https://doi.org/10.1182/blood-2019-125246

Published: 2019

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Li Mei Poon, MBBS, MRCP, FRCPath, Yeh Ching Linn, MBBS, MRCP, Poh Lin Tan, Ziyi LIM, Balamurugan Vellayappan, Rajat Bhattacharyya, Ah Moy Tan, MD, Lip Kun Tan, MBBS, FRCP, FRCPath, Teck Guan Soh, Colin Phipps Diong, Wing H. Leung, MD PhD, Liang Piu Koh, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 2039.

https://doi.org/10.1182/blood-2019-128014

Published: 2019

Journal Articles

Immunophenotypic and Genetic Characteristics of Diffuse Large B-Cell Lymphoma (DLBCL), and Prognostic Significance of Cell of Origin (COO) in a Southeast Asian Cohort

Vanessa CL Chong, Eng Soo Yap, MBBS, Liu Xin, Suk Teng Chin, Anand Jeyasekharan, Yen-Lin Chee, MBBS, MRCP, FRCPath, Hian Li Esther Chan, MBBS, Sanjay De Mel, Joanne Shu Xian Lee, MBBS, MRCP, Yee Mei Lee, Yi Ching Yuen, BPharm, Liang Piu Koh, MBBS, MRCP, Michelle Poon, MD

Blood (2018) 132 (Supplement 1): 4222.

https://doi.org/10.1182/blood-2018-99-119672

Published: 2018

Journal Articles

Single Institution Phase 1 Study on Combination Therapy of Midostaurin and Panobinostat in Acute Myeloid Leukemia - the Interim Report

Chin-Hin NG, MD MRCP, FRPATH, Liang Piu Koh, MBBS, MRCP, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Wei Ying Jen, MA, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS

Blood (2018) 132 (Supplement 1): 5237.

https://doi.org/10.1182/blood-2018-99-120327

Published: 2018

Journal Articles

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Blood (2018) 132 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2018-99-118364

Published: 2018

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Alpha Beta and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies

Liang Piu Koh, MBBS, MRCP, Wing H. Leung, MD PhD, Michelle Poon, Lip Kun Tan, Poh Lin Tan, Balamurugan Vellayappan, Rajat Bhattacharyya, Ah Moy Tan, MD, Teck Guan Soh, Yeh Ching Linn, MBBS, MRCP

Blood (2018) 132 (Supplement 1): 2093.

https://doi.org/10.1182/blood-2018-99-116296

Published: 2018

Journal Articles

The M351T BCR-ABL Kinase Mutation Is Uncommon in Asian Patients with Imatinib-Resistant Chronic Myeloid Leukemia: Possible Relationship with Imatinib Plasma Levels.

Ai Leen Ang, MBBS, Zhen Ping Wang, PhD, Li Yi Yang, BSc, Vallalan Natesan, MSc, Michelle Poon, MBBS, Liang Piu Koh, MBBS, Yeow Tee Goh, MBBS, Balram Chowbay, PhD, Charles Chuah, MBChB, MD

Blood (2008) 112 (11): 2122.

https://doi.org/10.1182/blood.V112.11.2122.2122

Published: 2008

NARROW

Use of Peripherally Inserted Central Catheter (PICC) for the Infusion of Peripheral Blood Stem Cell Products Is Safe and Effective

Prognostic Value of Refined Disease Risk Index (rDRI) and Conditioning Regimen in Adult Patients Receiving Unrelated Cord Blood Transplantation (UCBT) for Haematological Malignancies - 15-Year Follow-up of Multicenter Study in Singapore

Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2 (JAK2), in Patients with Intermediate-2 or High-Risk Myelofibrosis (MF): Updated Results from the Randomized, Placebo-Controlled, Phase III JAKARTA Trial

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies: Three-Year Follow-up of Multicenter Study in Singapore

High Dose Flamsa, CLAG or FLAG-Based Sequential Conditioning Regimen Followed By Allogeneic Hematopoietic Transplantation Results in Favorable Outcome for High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasia Patients : A Multicenter Study in Singapore

Autologous Stem Cell Transplantation (ASCT) for T-Cell Non Hodgkin Lymphoma (T-NHL) Patients Who Achieve Complete Remission with First-Line Treatment: A Systematic Review and Meta-Analysis

Unmanipulated Haploidentical Transplant Followed By Post-Transplant Cyclophosphamide and Selective Ex Vivo T-Cell Depleted Haploidentical Transplant Results in Comparable Outcome As Unrelated Cord Blood Transplant for Adults with Haematological Malignancies- a Multicenter Study in Singapore

High Dose Flamsa, CLAG or FLAG-Based Sequential Conditioning Regimen Followed By Allogeneic Hematopoietic Transplantation Results in Favorable Outcome for High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasia Patients: A Multicenter Study in Singapore

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Immunophenotypic and Genetic Characteristics of Diffuse Large B-Cell Lymphoma (DLBCL), and Prognostic Significance of Cell of Origin (COO) in a Southeast Asian Cohort

Single Institution Phase 1 Study on Combination Therapy of Midostaurin and Panobinostat in Acute Myeloid Leukemia - the Interim Report

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Alpha Beta and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies

The M351T BCR-ABL Kinase Mutation Is Uncommon in Asian Patients with Imatinib-Resistant Chronic Myeloid Leukemia: Possible Relationship with Imatinib Plasma Levels.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only